Headache-App Ratings Cannot Establish That Cannabis Concentrates Outperform Flower
An association between cannabis product type and symptom relief does not establish that concentrates are a superior headache treatment. A cannabis-app analysis reported larger headache-rating reductions with concentrates than flower, but product choice was not randomized.
Repeated sessions provided the records
The study analyzed Strainprint entries covering 12,293 headache sessions and 7,441 migraine sessions. Users recorded symptoms before and after cannabis use. These are use sessions, not that many independently recruited patients.
What the analysis reported
Headache and migraine ratings decreased significantly after use. Men reported larger headache reductions than women, and concentrate use was associated with larger headache reductions than flower use. The abstract also described diminishing effects and increasing doses over time as evidence suggestive of tolerance.
Product choice can carry other differences
People may choose concentrates because their symptoms, experience, preferences or prior response differ. Products can also differ in delivered dose and use conditions. A statistical association in self-selected app records cannot by itself isolate product formulation as the cause of the difference.
The before-and-after rating change likewise lacks a randomized untreated or placebo comparison. Symptoms can fluctuate, and records may preferentially capture certain experiences. These limitations do not erase the reported improvement; they define what it establishes. A treatment claim should distinguish immediate self-reported relief, comparative product efficacy and possible change with repeated use. None of those outcomes supplies a laboratory marker of impairment or a clinical recommendation to escalate potency.
Related: interpreting cannabis tolerance claims.
Research cited
Cuttler C; Spradlin A; Cleveland MJ; Craft RM. Short- and Long-Term Effects of Cannabis on Headache and Migraine. The journal of pain (2020). doi:10.1016/j.jpain.2019.11.001. Findings discussed from the study abstract.
